Literature DB >> 3059925

The functional output of the mesolimbic dopamine system.

G F Koob1, N R Swerdlow.   

Abstract

In summary, the nucleus accumbens, located at the interface of the limbic projections from the amygdala, hippocampus, and cingulate cortex, and receiving extrapyramidal fibers from midbrain DA-containing nuclei, is well situated to form neural circuitry that mediates the behaviorally activating properties of several stimulants. Efferent GABAergic fibers projecting from the nucleus accumbens to the ventral pallidum translate integrated limbic and extrapyramidal information to lower motor circuitry; some of this information appears to be carried by ventral pallidal efferent fibers projecting to the dorsomedial nucleus of the thalamus. It seems very possible that activation of this circuitry by positive reinforcing environmental stimuli, through the release of endogenous DA or opiate compounds, might contribute to motivated behavior. Indeed, environmentally generated locomotor activity can be blocked by disruption of this circuitry following destruction of N. Acc. DA terminals. It is also tempting to speculate that pathological changes in activity within this system might disrupt normal reinforcement contingencies, and contribute to the affective components of both psychiatric and neurologic disease states.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3059925     DOI: 10.1111/j.1749-6632.1988.tb42108.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  35 in total

1.  Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior.

Authors:  Krista McFarland; Christopher C Lapish; Peter W Kalivas
Journal:  J Neurosci       Date:  2003-04-15       Impact factor: 6.167

Review 2.  Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits.

Authors:  J D Salamone; M Correa; A Farrar; S M Mingote
Journal:  Psychopharmacology (Berl)       Date:  2007-01-16       Impact factor: 4.530

3.  Forebrain circuitry involved in effort-related choice: Injections of the GABAA agonist muscimol into ventral pallidum alter response allocation in food-seeking behavior.

Authors:  A M Farrar; L Font; M Pereira; S Mingote; J G Bunce; J J Chrobak; J D Salamone
Journal:  Neuroscience       Date:  2008-01-01       Impact factor: 3.590

Review 4.  Neuromodulation for obsessive-compulsive disorder.

Authors:  Kyle A B Lapidus; Emily R Stern; Heather A Berlin; Wayne K Goodman
Journal:  Neurotherapeutics       Date:  2014-07       Impact factor: 7.620

5.  GABAB receptor cell-surface export is controlled by an endoplasmic reticulum gatekeeper.

Authors:  S Doly; H Shirvani; G Gäta; F J Meye; M-B Emerit; H Enslen; L Achour; L Pardo-Lopez; S-K Yang; V Armand; R Gardette; B Giros; M Gassmann; B Bettler; M Mameli; M Darmon; S Marullo
Journal:  Mol Psychiatry       Date:  2015-06-02       Impact factor: 15.992

6.  The effects of infusions of CART 55-102 into the basolateral amygdala on amphetamine-induced conditioned place preference in rats.

Authors:  David J Rademacher; Elyse M Sullivan; David A Figge
Journal:  Psychopharmacology (Berl)       Date:  2009-12-16       Impact factor: 4.530

7.  Inactivation of the maternal fragile X gene results in sensitization of GABAB receptor function in the offspring.

Authors:  Bojana Zupan; Miklos Toth
Journal:  J Pharmacol Exp Ther       Date:  2008-09-23       Impact factor: 4.030

8.  The multifaceted effects of oral administration of methylphenidate in juvenile rats: anxiety, activity, and attention.

Authors:  Ning Zhu; Jeremy Weedon; Diana L Dow-Edwards
Journal:  Eur Neuropsychopharmacol       Date:  2010-01-18       Impact factor: 4.600

9.  Adolescent development of the reward system.

Authors:  Adriana Galvan
Journal:  Front Hum Neurosci       Date:  2010-02-12       Impact factor: 3.169

10.  Two types of neurone in the rat ventral tegmental area and their synaptic inputs.

Authors:  S W Johnson; R A North
Journal:  J Physiol       Date:  1992-05       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.